GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Range Low Price High Price Comment
30 days $2.77 $4.97 Friday, 19th Apr 2024 ALDX stock ended at $3.86. This is 3.02% less than the trading day before Thursday, 18th Apr 2024. During the day the stock fluctuated 5.28% from a day low at $3.79 to a day high of $3.99.
90 days $2.71 $4.97
52 weeks $1.42 $11.97

Historical Aldeyra Therapeutics prices

Date Open High Low Close Volume
2023-05-26 $9.33 $9.46 $9.13 $9.37 684 700
2023-05-25 $9.66 $9.66 $9.15 $9.20 818 853
2023-05-24 $9.75 $9.85 $9.53 $9.61 730 983
2023-05-23 $9.76 $9.99 $9.70 $9.82 567 769
2023-05-22 $9.89 $10.07 $9.74 $9.76 559 623
2023-05-19 $9.72 $9.96 $9.72 $9.85 832 609
2023-05-18 $9.81 $9.90 $9.56 $9.65 668 898
2023-05-17 $10.01 $10.06 $9.77 $9.85 648 850
2023-05-16 $10.07 $10.28 $9.93 $10.02 575 658
2023-05-15 $10.19 $10.32 $10.14 $10.21 444 822
2023-05-12 $10.30 $10.35 $10.05 $10.16 561 521
2023-05-11 $10.20 $10.42 $10.11 $10.35 624 158
2023-05-10 $10.36 $10.50 $10.10 $10.23 569 938
2023-05-09 $10.57 $10.71 $10.05 $10.26 681 219
2023-05-08 $10.71 $10.74 $10.35 $10.66 687 800
2023-05-05 $10.46 $10.81 $10.40 $10.57 654 929
2023-05-04 $10.35 $10.46 $9.89 $10.39 728 090
2023-05-03 $10.15 $10.43 $10.11 $10.18 451 936
2023-05-02 $10.11 $10.40 $10.00 $10.18 710 582
2023-05-01 $9.53 $10.16 $9.50 $10.08 556 712
2023-04-28 $9.07 $9.63 $9.00 $9.53 538 979
2023-04-27 $9.06 $9.44 $9.00 $9.05 910 454
2023-04-26 $9.26 $9.23 $8.96 $9.07 627 554
2023-04-25 $9.48 $9.54 $8.97 $9.08 1 067 698
2023-04-24 $10.02 $10.11 $8.97 $9.45 2 174 292
Click to get the best stock tips daily for free!

About Aldeyra Therapeutics

Aldeyra Therapeutics Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It also develops ADX-629, a first-in-class orally administered RASP modulator that is Phase II clinical tria... ALDX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT